• 00Days
  • 00Hours
  • 00Minutes
  • 00Seconds




Find us at Stand 56

Baroque Medical was established in 1994. 
Baroque Medical, through its focus on customer needs, continues to be the Partner of Choice through the marketing, sales and distribution of reputable products that ensure better patient outcomes.

Our commitment to the advance of the standard of patient care is underpinned by our ability to supply products of exceptional quality and furthermore by our offering of unbiased educational programs to healthcare professionals in their stated disciplines under the auspices of world leading professionals.

Abbott Vascular, together with Baroque Medical, bring you extensively researched products, such as Xience; solutions from diagnosis to closure (Proglide); staying updated with the latest on Physiology (FFR) and Imaging (OCT)

We are committed to continued medical education through the unrestricted grant to the Crossroads Education Institute. Where science, education and medical professionals meet.

Baroque Medical’s continued culture of support ensures that we’re in it with you Heart, Mind, Body and Soul.

Find us at Stand 10

Improving the health of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.

Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2018, Boehringer Ingelheim achieved net sales of around 17.5 billion euros. R&D expenditure of almost 3.2 billion euros corresponded to 18.1 per cent of net sales.

As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards humankind and the environment.

More information about Boehringer Ingelheim can be found on or in our annual report:

Find us at Stand 55

Find us at Stand 36

We believe innovation that produces breakthrough medicines and products will be more important than ever in the healthcare industry in the coming years.

We maintain substantial investment in research and de­­velopment (R&D) aimed at areas of unmet medical need. Our product pipeline is fed by a distinctive research and clinical approach that focuses on scientific advances before market ­potential

Find us at Stand 9

At Sanofi, our passion is to prevent, treat and cure illness and disease throughout life. We are driven to improve the health of communities and to find new solutions for patients by combining break-through science with advanced technology. We are always working to find new ways to fight chronic, complex and rare diseases with medicines that offer hope for patients in the future of healthcare.

Find us at Stand 38

We are an international and independent pharmaceutical company governed by a non-profit foundation, with headquarters in Suresnes, France.

Operating in 149 countries, we have 22,000 collaborators employed worldwide and a turnover of 4.176 billion euros in 2018. Entirely independent, we are able to reinvest 25% of our total revenue (excluding generics) into Research and Development, and all profits are used for further development.
Corporate growth at Servier is driven by our continuous pursuit of innovation in five areas of excellence: cardiovascular and immune-inflammatory diseases, neuropsychiatric disorders, cancer and diabetes. We are a leading force in cardiology—number 2 in Europe, number 5 worldwide—and oncology has become a top priority in recent years; we also manufacture high-quality generic drugs.
Becoming a key player in oncology is part of Servier’s long-term strategy. Currently, there are nine molecular entities in clinical development in this area, targeting gastric and lung cancers and other solid tumors, as well as various leukemias and lymphomas. This portfolio of innovative cancer treatments is being developed with partners worldwide, and covers different cancer hallmarks and modalities, including cytotoxics, proapoptotics, targeted, immune and cellular therapies.

Find us at Stand 37

Is a proudly South African Company marketing and distributing high quality medical supplies and devices to private and state hospitals for the past 17 years. A fully compliant B-BBEE Level 1 company

We believe every individual deserves to be treated with the best and latest in medical technology & advancements, no matter the individual’s status. Therefore, partnering with global leading manufacturers in the industry that share in our vision, has been essential to maintaining our value system.  Our focus  over the recent years, is to supply ground breaking minimally invasive coronary intervention devices and accessories that constantly improve  the needs of the patient, clinician and healthcare system in South Africa.  We are a company that is passionate about medicine and compassionate about our people.

Find us at Stand 1 & 19

Vertice Cardiovascular delivers diagnostic and interventional innovations that have been developed in collaboration with clinical experts.

Our strategic partnerships with global market leaders such as Abbott, Asahi, Numed, Shockwave, SIS, Terumo and Wellinq enable us to offer high-performance cardiac solutions that improve patient treatments and optimise surgical workflows to give surgeons greater control over complex surgical interventions.


Find us at Stand 43

Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.

Edwards leadership in transcatheter heart valve replacement includes a commitment to meaningful innovation, rigorous scientific study, extensive clinician training and education, and significant investment in new applications of the technology. The Edwards SAPIEN valve platform continues to raise the bar as the most widely studied transcatheter heart valve worldwide.

Helping patients is our life’s work, and life is now.

MedTech Approval in Process  ||  Ref No EMT 29392

About the Sandton Convention Centre

Sandton Convention Centre is the Premier Exhibition, Conference & Events Destination in Africa and South Africa’s leading event venue, offering prestigious multi-use event spaces and venues in the financial hub of Johannesburg. It is conveniently located in the vibrant business district of Sandton in northern Johannesburg and within easy reach of the Gautrain and O. R. Tambo International Airport. The Sandton Convention Centre (SCC) is flanked by a number of leading hotels, sophisticated shopping centres and entertainment complexes.

Scroll to Top